DEUTSCHE BANK AG\ - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 64 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.5%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$1,000
-95.2%
1,900
-90.8%
0.00%
Q1 2020$21,000
-36.4%
20,701
-5.8%
0.00%
Q4 2019$33,000
+13.8%
21,974
+33.9%
0.00%
Q3 2019$29,000
-29.3%
16,410
-35.3%
0.00%
Q2 2019$41,00025,347
+5072.9%
0.00%
Q1 2019$0
-100.0%
490
-87.7%
0.00%
Q3 2018$14,000
+100.0%
3,990
+17.4%
0.00%
Q2 2018$7,0003,4000.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
CVI Holdings, LLC 1,484,714$2,658,0002.52%
ESSEX INVESTMENT MANAGEMENT CO LLC 549,750$984,0000.14%
BARD ASSOCIATES INC 88,184$158,0000.08%
EAM Investors, LLC 160,628$288,0000.07%
Regal Investment Advisors LLC 193,450$346,0000.07%
HighTower Advisors, LLC 5,284,838$9,460,0000.06%
HIGHLAND CAPITAL MANAGEMENT LP 545,000$976,0000.06%
Granite Point Capital Management, L.P. 329,000$589,0000.06%
Kore Private Wealth LLC 104,366$187,0000.04%
Verition Fund Management LLC 498,167$892,0000.04%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders